The Medical Technologies, Biotechnologies and Pharmaceuticals Industry Growth Centre – and trade group Medicines Australia, have signed a memorandum of understanding (MoU) to work collaboratively to boost the innovative pharmaceutical industry in Australia.
The collaboration will see the two organizations combining their efforts to champion a sector-led approach to accelerate the growth of the ecosystem, through activities to unify and educate the medical technology, biotechnology and pharmaceutical (MTP) sector, as well as engage with government to create a positive regulatory environment.
Together, MTPConnect and Medicines Australia will support the innovative medicines and vaccines industry to:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze